Atlantic Canadians deserve better cancer treatment options and conditions to deal with cancer’s effects on themselves, their families, and health-care systems. The most recent estimates predicts that almost 45 per cent of Canadians will be diagnosed with cancer during their lives.
With the tremendous financial support by the Terry Fox Research Institute and other funders, researchers and clinicians from three Atlantic Provinces – Newfoundland and Labrador, Nova Scotia and New Brunswick – came together to form the Marathon of Hope Atlantic Cancer Consortium (MoH ACC) in 2021.
The MoH ACC aims to contribute to this aim through high-quality cancer research and extensive collaborations among the regional experts and centres. This consortium focuses on precision medicine and consists of more than 60 investigators with diverse experience and multidisciplinary expertise.
Please visit the website to read the full article: https://gazette.mun.ca/public-engagement/personalized-and-effective/